Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.250
-0.080 (-6.02%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Repare Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 84.72 | 111.27 | 159.52 | 334.43 | 326.18 | Upgrade
|
| Short-Term Investments | 68.07 | 112.36 | 184.42 | 7.44 | 7.53 | Upgrade
|
| Cash & Short-Term Investments | 152.79 | 223.63 | 343.94 | 341.87 | 333.71 | Upgrade
|
| Cash Growth | -31.68% | -34.98% | 0.61% | 2.44% | 252.03% | Upgrade
|
| Accounts Receivable | 0.93 | 1.13 | 1.53 | - | - | Upgrade
|
| Other Receivables | 11.42 | 14.18 | 2.8 | 3.23 | 6.16 | Upgrade
|
| Receivables | 12.35 | 15.31 | 4.32 | 3.23 | 6.16 | Upgrade
|
| Prepaid Expenses | 6.01 | 4.75 | 5.72 | 6.31 | 6.68 | Upgrade
|
| Total Current Assets | 171.15 | 243.69 | 353.98 | 351.41 | 346.55 | Upgrade
|
| Property, Plant & Equipment | 4.22 | 7.54 | 9.6 | 13.1 | 8.62 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 3.62 | 1.41 | Upgrade
|
| Other Long-Term Assets | 1.14 | 2.67 | 0.5 | 0.59 | 0.5 | Upgrade
|
| Total Assets | 176.51 | 253.9 | 364.08 | 368.72 | 357.09 | Upgrade
|
| Accounts Payable | 3.62 | 2.4 | 0.46 | 2.3 | 2.25 | Upgrade
|
| Accrued Expenses | 19.65 | 23.86 | 21.37 | 16.53 | 5.79 | Upgrade
|
| Current Portion of Leases | 1.85 | 2.4 | 2.17 | 1.72 | 0.7 | Upgrade
|
| Current Income Taxes Payable | - | - | 1.24 | 0.52 | 0.02 | Upgrade
|
| Current Unearned Revenue | - | 10.22 | 53.1 | 11.92 | 2.07 | Upgrade
|
| Other Current Liabilities | 0.17 | 0.19 | 0.27 | 2.1 | 0.18 | Upgrade
|
| Total Current Liabilities | 25.29 | 39.08 | 78.62 | 35.09 | 11.01 | Upgrade
|
| Long-Term Leases | 0.09 | 1.01 | 3.26 | 5.59 | 3.31 | Upgrade
|
| Long-Term Unearned Revenue | - | 1.73 | 2.68 | 39.61 | 55.93 | Upgrade
|
| Total Liabilities | 25.38 | 41.82 | 84.56 | 80.29 | 70.26 | Upgrade
|
| Common Stock | 486.67 | 483.35 | 482.03 | 480.7 | 384.31 | Upgrade
|
| Additional Paid-In Capital | 82.19 | 61.81 | 37.23 | 17.99 | 5.88 | Upgrade
|
| Retained Earnings | -417.8 | -333.11 | -239.31 | -210.27 | -103.36 | Upgrade
|
| Comprehensive Income & Other | 0.06 | 0.03 | -0.43 | - | - | Upgrade
|
| Total Common Equity | 151.13 | 212.08 | 279.52 | 288.42 | 286.83 | Upgrade
|
| Shareholders' Equity | 151.13 | 212.08 | 279.52 | 288.42 | 286.83 | Upgrade
|
| Total Liabilities & Equity | 176.51 | 253.9 | 364.08 | 368.72 | 357.09 | Upgrade
|
| Total Debt | 1.93 | 3.41 | 5.43 | 7.31 | 4.01 | Upgrade
|
| Net Cash (Debt) | 150.86 | 220.22 | 338.51 | 334.55 | 329.71 | Upgrade
|
| Net Cash Growth | -31.50% | -34.95% | 1.18% | 1.47% | 251.75% | Upgrade
|
| Net Cash Per Share | 3.56 | 5.23 | 8.07 | 8.85 | 16.45 | Upgrade
|
| Filing Date Shares Outstanding | 42.51 | 42.18 | 42.08 | 41.87 | 36.9 | Upgrade
|
| Total Common Shares Outstanding | 42.51 | 42.18 | 42.04 | 41.85 | 36.9 | Upgrade
|
| Working Capital | 145.86 | 204.61 | 275.36 | 316.33 | 335.54 | Upgrade
|
| Book Value Per Share | 3.56 | 5.03 | 6.65 | 6.89 | 7.77 | Upgrade
|
| Tangible Book Value | 151.13 | 212.08 | 279.52 | 288.42 | 286.83 | Upgrade
|
| Tangible Book Value Per Share | 3.56 | 5.03 | 6.65 | 6.89 | 7.77 | Upgrade
|
| Machinery | 8.95 | 8.97 | 7.06 | 6.51 | 5.24 | Upgrade
|
| Leasehold Improvements | 2.55 | 2.55 | 2.52 | 2.47 | 0.71 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.